Page 9 - 2019_05-HaematologicaMondo-web

http://www.haematologica.org/content/104/5/e187
e191 Autophagic degradation determines the fate of T315I-mutated BCR-ABL protein Haruka Shinohara et al.
http://www.haematologica.org/content/104/5/e191
e195 Clinical and molecular features of acute promyelocytic leukemia with variant retinoid acid receptor fusions Lijun Wen et al.
http://www.haematologica.org/content/104/5/e195
e200 Mutational and transcriptomic profiling of acute leukemia of ambiguous lineage reveals obscure but clinically important lineage bias Zhen-Tang Lao et al.
http://www.haematologica.org/content/104/5/e200
e204 T-cell acute lymphoblastic leukemias express a unique truncated FAT1 isoform that cooperates with NOTCH1 in leukemia development Charles E. de Bock et al.
http://www.haematologica.org/content/104/5/e204
e208 Long-term real-world results of ibrutinib therapy in patients with relapsed or refractory chronic lymphocytic leukemia: 30-month follow up of the Swedish compassionate use cohort
Maria Winqvist et al.
http://www.haematologica.org/content/104/5/e208
e211 Ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma: extended 3.5-year follow up from a pooled analysis Simon Rule et al.
http://www.haematologica.org/content/104/5/e211
e215 A prospective description of HIV-associated multicentric Castleman disease in Malawi Tamiwe Tomoka et al.
http://www.haematologica.org/content/104/5/e215
Case Reports
Case Reports are available online only at www.haematologica.org/content/104/5.toc
e218 Leukemic presentation of ALK-positive anaplastic large cell lymphoma with a novel partner, poly(A) binding protein cytoplasmic 1 (PABPC1), responding to single-agent crizotinib
Dylan Graetz et al.
http://www.haematologica.org/content/104/5/e218
e222 Venetoclax penetrates in cerebrospinal fluid and may be effective in chronic lymphocytic leukemia with central nervous system involvement.
Gianluigi Reda et al. http://www.haematologica.org/content/104/5/e222
e224 Venetoclax plus rituximab or obinutuzumab after allogeneic hematopoietic stem cell transplantation in chronic lymphocytic leukemia Othman Al-Sawaf et al.
http://www.haematologica.org/content/104/5/e224
Comments
Comments are available online only at www.haematologica.org/content/104/5.toc
e227 Identifying potential factors of variable response to mogamulizumab in adult T-cell leukemia/lymphoma between Japanese and other pop- ulations
Murali Janakiram et al. http://www.haematologica.org/content/104/5/e227
e228 Response to the comment: “Identifying potential factors of variable response to mogamulizumab in adult T-cell leukemia/lymphoma between Japanese and other populations”
Adrienne A. Phillips
http://www.haematologica.org/content/104/5/e227
Retraction
e229 GRP94 rewires and buffers the FLT3-ITD signaling network and promotes survival of acute myeloid leukemic stem cells Beibei Zhang et al.
haematologica Journal of the Ferrata Storti Foundation
http://www.haematologica.org/content/104/5/e229
Haematologica 2019; vol. 104 no. 5 - May 2019 http://www.haematologica.org/